Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential

Sang Bum Kim, Deokjae Lee, Joo Won Jeong, Chungho Kim, Dongeun Park, Moon Gyo Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Epithin (PRSS14/matriptase/ST14), a type II membrane protein, is involved in progression of epithelial cancers and metastasis as well as in the normal epidermal barrier function. When activated, it translocates into the cell-cell contacts and sheds into media. In order to understand the specific mechanism during tumor progression, we tested the angiogenic potential of secreted form of epithin. Epithin produced from the cancer cells shed more in hypoxia and induced motility of endothelial cells. Epithin enhanced the migration and invasion of mouse and bovine endothelial cells without cell proliferation. Furthermore, soluble epithin induced endothelial differentiation in the assay of the human endothelial microvessel-like tube formation and in that of the chicken chorioallantoic membrane. The knock-down of epithin in the 427 thymoma cell line abolished the protease activity of secreted epithin fraction, reduced the invasion of endothelial cells through matrigel, and tube formation activity. Only specific antibodies abolished the migration of endothelial cell and the vessel morphogenesis, suggesting that epithin specifically functions in these systems. Therefore, we propose that the secreted epithin in the hypoxic cancer microenvironment plays a role as a proangiogenic factor, and can be modulated with specific antibodies.

Original languageEnglish
Pages (from-to)617-623
Number of pages7
JournalMolecules and Cells
Volume29
Issue number6
DOIs
Publication statusPublished - 2010 Jun 1
Externally publishedYes

Fingerprint

Endothelial Cells
Neoplasms
Chorioallantoic Membrane
Tumor Microenvironment
Thymoma
Antibodies
Microvessels
Morphogenesis
Chickens
Membrane Proteins
Peptide Hydrolases
Cell Proliferation
Neoplasm Metastasis
Cell Line

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential. / Kim, Sang Bum; Lee, Deokjae; Jeong, Joo Won; Kim, Chungho; Park, Dongeun; Kim, Moon Gyo.

In: Molecules and Cells, Vol. 29, No. 6, 01.06.2010, p. 617-623.

Research output: Contribution to journalArticle

Kim, Sang Bum ; Lee, Deokjae ; Jeong, Joo Won ; Kim, Chungho ; Park, Dongeun ; Kim, Moon Gyo. / Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential. In: Molecules and Cells. 2010 ; Vol. 29, No. 6. pp. 617-623.
@article{d188db64bbcb410d84b66e4b02af880a,
title = "Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential",
abstract = "Epithin (PRSS14/matriptase/ST14), a type II membrane protein, is involved in progression of epithelial cancers and metastasis as well as in the normal epidermal barrier function. When activated, it translocates into the cell-cell contacts and sheds into media. In order to understand the specific mechanism during tumor progression, we tested the angiogenic potential of secreted form of epithin. Epithin produced from the cancer cells shed more in hypoxia and induced motility of endothelial cells. Epithin enhanced the migration and invasion of mouse and bovine endothelial cells without cell proliferation. Furthermore, soluble epithin induced endothelial differentiation in the assay of the human endothelial microvessel-like tube formation and in that of the chicken chorioallantoic membrane. The knock-down of epithin in the 427 thymoma cell line abolished the protease activity of secreted epithin fraction, reduced the invasion of endothelial cells through matrigel, and tube formation activity. Only specific antibodies abolished the migration of endothelial cell and the vessel morphogenesis, suggesting that epithin specifically functions in these systems. Therefore, we propose that the secreted epithin in the hypoxic cancer microenvironment plays a role as a proangiogenic factor, and can be modulated with specific antibodies.",
keywords = "angiogenesis, epithin, hypoxia, matriptase, PRSS14",
author = "Kim, {Sang Bum} and Deokjae Lee and Jeong, {Joo Won} and Chungho Kim and Dongeun Park and Kim, {Moon Gyo}",
year = "2010",
month = "6",
day = "1",
doi = "10.1007/s10059-010-0077-0",
language = "English",
volume = "29",
pages = "617--623",
journal = "Molecules and Cells",
issn = "1016-8478",
publisher = "Korean Society for Molecular and Cellular Biology",
number = "6",

}

TY - JOUR

T1 - Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential

AU - Kim, Sang Bum

AU - Lee, Deokjae

AU - Jeong, Joo Won

AU - Kim, Chungho

AU - Park, Dongeun

AU - Kim, Moon Gyo

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Epithin (PRSS14/matriptase/ST14), a type II membrane protein, is involved in progression of epithelial cancers and metastasis as well as in the normal epidermal barrier function. When activated, it translocates into the cell-cell contacts and sheds into media. In order to understand the specific mechanism during tumor progression, we tested the angiogenic potential of secreted form of epithin. Epithin produced from the cancer cells shed more in hypoxia and induced motility of endothelial cells. Epithin enhanced the migration and invasion of mouse and bovine endothelial cells without cell proliferation. Furthermore, soluble epithin induced endothelial differentiation in the assay of the human endothelial microvessel-like tube formation and in that of the chicken chorioallantoic membrane. The knock-down of epithin in the 427 thymoma cell line abolished the protease activity of secreted epithin fraction, reduced the invasion of endothelial cells through matrigel, and tube formation activity. Only specific antibodies abolished the migration of endothelial cell and the vessel morphogenesis, suggesting that epithin specifically functions in these systems. Therefore, we propose that the secreted epithin in the hypoxic cancer microenvironment plays a role as a proangiogenic factor, and can be modulated with specific antibodies.

AB - Epithin (PRSS14/matriptase/ST14), a type II membrane protein, is involved in progression of epithelial cancers and metastasis as well as in the normal epidermal barrier function. When activated, it translocates into the cell-cell contacts and sheds into media. In order to understand the specific mechanism during tumor progression, we tested the angiogenic potential of secreted form of epithin. Epithin produced from the cancer cells shed more in hypoxia and induced motility of endothelial cells. Epithin enhanced the migration and invasion of mouse and bovine endothelial cells without cell proliferation. Furthermore, soluble epithin induced endothelial differentiation in the assay of the human endothelial microvessel-like tube formation and in that of the chicken chorioallantoic membrane. The knock-down of epithin in the 427 thymoma cell line abolished the protease activity of secreted epithin fraction, reduced the invasion of endothelial cells through matrigel, and tube formation activity. Only specific antibodies abolished the migration of endothelial cell and the vessel morphogenesis, suggesting that epithin specifically functions in these systems. Therefore, we propose that the secreted epithin in the hypoxic cancer microenvironment plays a role as a proangiogenic factor, and can be modulated with specific antibodies.

KW - angiogenesis

KW - epithin

KW - hypoxia

KW - matriptase

KW - PRSS14

UR - http://www.scopus.com/inward/record.url?scp=77955020372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955020372&partnerID=8YFLogxK

U2 - 10.1007/s10059-010-0077-0

DO - 10.1007/s10059-010-0077-0

M3 - Article

C2 - 20652801

AN - SCOPUS:77955020372

VL - 29

SP - 617

EP - 623

JO - Molecules and Cells

JF - Molecules and Cells

SN - 1016-8478

IS - 6

ER -